Navamedic ASA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
Provider: Wright Reports
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Navamedic ASA Issues H2 2013 Net Result Guidance
Navamedic ASA announced that it expects to report positive net result for the second half of 2013.
Latest Developments for Navamedic ASA
Latest Key Developments in Pharmaceuticals
- Chembio Diagnostics Inc appoints president and CEO
- Theravance Inc and GlaxoSmithKline plc announces positive results from studies comparing ANORO ELLIPTA With SERETIDE DISKUS and ADVAIR DISKUS in Patients With COPD
- Theravance Inc and GlaxoSmithKline Plc announces positive results from studies comparing ANORO ELLIPTA With SERETIDE DISKUS and ADVAIR DISKUS in Patients With COPD
- Cipher Pharmaceuticals Inc announces Larry Andrews will be stepping down as President and Chief Executive Officer
- Share this
- Digg this